BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Update

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) was the recipient of a large increase in short interest in January. As of January 15th, there was short interest totalling 3,200 shares, an increase of 10.3% from the December 31st total of 2,900 shares. Based on an average daily volume of 154,200 shares, the days-to-cover ratio is currently 0.0 days.

BriaCell Therapeutics Price Performance

Shares of BCTXW traded up $0.00 during midday trading on Monday, hitting $0.17. The company had a trading volume of 363,661 shares, compared to its average volume of 118,248. The company’s 50 day moving average price is $0.28 and its 200 day moving average price is $0.27. BriaCell Therapeutics has a 52 week low of $0.11 and a 52 week high of $1.89.

About BriaCell Therapeutics

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.